Linezolid and Metastases to liver - a phase IV clinical study of FDA data

Summary:

Metastases to liver is reported as a side effect among people who take Linezolid (linezolid), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Vancomycin, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Metastases to liver when taking Linezolid. It is created by eHealthMe based on reports of 21,827 people who have side effects when taking Linezolid from the FDA, and is updated regularly.

What is Linezolid?

Linezolid has active ingredients of linezolid. It is often used in infection. eHealthMe is studying from 21,891 Linezolid users. Check the latest studies of Linezolid.

What is Metastases to liver?

Metastases to liver (cancer spreads to liver) is found to be associated with 1,039 drugs and 999 conditions by eHealthMe. Check the latest studies of Metastases to liver.



On Jul, 21, 2026

21,827 people reported to have side effects when taking Linezolid.
Among them, 28 people (0.13%) have Metastases to liver.

Could Linezolid cause Metastases to liver?

Among these 28 people:

How long have people been on Linezolid when they have Metastases to liver? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Metastases to liver when taking Linezolid? *

  • female: 32 %
  • male: 68 %

What is the age of people who have Metastases to liver when taking Linezolid? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 32 %
  • 30-39: 0.0 %
  • 40-49: 64 %
  • 50-59: 4 %
  • 60+: 0.0 %

What are other drugs people take besides Linezolid? *

  1. Vancomycin: 26 people, 92.86%
  2. Gemcitabine: 15 people, 53.57%
  3. Carmustine: 8 people, 28.57%
  4. Bendamustine: 5 people, 17.86%
  5. Oxaliplatin: 2 people, 7.14%
  6. Dexamethasone: 1 person, 3.57%
  7. Blincyto: 1 person, 3.57%
  8. Carboplatin: 1 person, 3.57%
  9. Cyclophosphamide: 1 person, 3.57%
  10. Cytarabine: 1 person, 3.57%

What are other side effects people have besides Metastases to liver? *

  1. Metastases To Muscle (cancer spreads to muscle): 16 people, 57.14%
  2. Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 16 people, 57.14%
  3. Metastases To Bone Marrow (cancer spreads to bone marrow): 16 people, 57.14%
  4. Metastases To Lung (cancer spreads to lung): 16 people, 57.14%
  5. Metastases To Spleen (cancer spreads to spleen): 16 people, 57.14%
  6. Metastases To Retroperitoneum (cancer spreads to retroperitonium): 16 people, 57.14%
  7. Staphylococcal Infection (an infection with staphylococcus bacteria): 15 people, 53.57%
  8. Fever: 15 people, 53.57%
  9. Glomerular Filtration Rate Decreased: 15 people, 53.57%
  10. Interstitial Nephritis (inflammation of the kidney): 15 people, 53.57%

What are the existing conditions these people have? *

  1. Staphylococcal Infection (an infection with staphylococcus bacteria): 16 people, 57.14%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 16 people, 57.14%
  3. Diffuse Large B-Cell Lymphoma Stage Iii (cancer of b cells, a type of white blood cell-stage iii): 15 people, 53.57%
  4. Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 15 people, 53.57%
  5. Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 15 people, 53.57%
  6. Malignant Neoplasm Progression (cancer tumour came back): 14 people, 50.00%
  7. Device Related Infection: 14 people, 50.00%
  8. Burkitt Lymphoma (cancer of the lymphatic system): 14 people, 50.00%
  9. Bone Marrow Conditioning Regimen: 11 people, 39.29%
  10. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Linezolid and have Metastases to liver?

- Check whether Metastases to liver is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Linezolid:

Metastases to liver treatments and more:

How severe was Metastases to liver and when was it recovered:

Expand to all the drugs that have ingredients of linezolid:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Linezolid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastases to liver:

Browse all the conditions that are associated with Metastases to liver:


How the study uses the data?

The study uses data from the FDA. It is based on linezolid (the active ingredients of Linezolid) and Linezolid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: